Integrating Immunogenetics, Single-Cell Transcriptomics, and AI-Assisted Drug Discovery Reveals CXCL10-Associated Immune Remodelling in Breast Cancer.
Breast cancer is a heterogeneous malignancy shaped by genetic alterations and cytokine-mediated immune interactions. However, integrative characterization of cytokine-related regulators using genetic, single-cell, and computational approaches remains limited. This study aimed to identify genetically supported cytokine-...